Learn more

KLINGE CO CHEM PHARM FAB

Overview
  • Total Patents
    409
About

KLINGE CO CHEM PHARM FAB has a total of 409 patent applications. Its first patent ever was published in 1938. It filed its patents most often in Germany, United States and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are NEOCULI PTY LTD, INST MATERIA MEDICA CAMS and CELLCEUTIX CORP.

Patent filings per year

Chart showing KLINGE CO CHEM PHARM FABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Seibel Klaus 65
#2 Reiter Friedemann 62
#3 Biedermann Elfi 52
#4 Schein Barbara 50
#5 Grill Helmut 44
#6 Vogt Klaus 42
#7 Rattel Benno 42
#8 Hasmann Max 42
#9 Loeser Roland 40
#10 Schliack Michael 30

Latest patents

Publication Filing date Title
DE10043170A1 Amifostine monohydrate and process for its preparation
US6903118B1 Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
EP1031564A1 Inhibitors of cellular nicotinamide mononucleotide formation and their use in cancer therapy
DE19908483A1 Substances that inhibit cellular nicotinamide mononucleotide formation, useful for cancer therapy and immunosuppression
US6451816B1 Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
DE19818044A1 Reducing side effects or neutralizing action of carcinostatic or immunosuppressive agents, especially pyridine derivatives, using vitamin PP compounds, e.g. nicotinamide
DE19756235A1 New piperidinyl-substituted pyridylalkane alkene and alkane carboxylic acid amides
DE19756261A1 New aryl-substituted pyridylalkane, alkene and alkyarboxylic acid amides
DE19756236A1 Novel piperazinyl-substituted pyridylalkane, alkene and alkyarboxylic acid amides
DE19756212A1 New cyclic imide-substituted pyridylalkane, alkene and alkyarboxylic acid amides
US6077534A Production of pharmaceutical formulations for treatment of edema and venous disorders
KR20000022333A Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
WO9847534A1 Stabilized medicaments containing cysteinyl derivatives
DE19651551A1 Opioid antagonist-containing galenic formulation
DE19626045A1 A stable dosage form for oral administration containing omeprazole as the active ingredient and methods of making the same
DE19624659A1 New pyridylalkene and pyridylalkanoic acid amides
DE19624704A1 New pyridylalkanoic acid amides
DE19624668A1 Use of pyridylalkane, pyridylalken or pyridylalkynamides
DE19618999A1 New benzothiazolinones
DE19618970A1 New thiazolopyridines